Literature DB >> 2869703

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

D B Carr, D V Sheehan, O S Surman, J H Coleman, D J Greenblatt, G R Heninger, K J Jones, P H Levine, W D Watkins.   

Abstract

Lactate infusions are anxiogenic in patients with panic disorder or agoraphobia with panic attacks, but few neuroendocrine profiles of this effect have appeared. The authors measured the number and intensity of panic symptoms and blood hormone levels during double-blind lactate infusions in 25 patients and 10 normal subjects and during placebo infusions in another five patients. Each patient was rechallenged with an identical infusate after chronic double-blind outpatient treatment with alprazolam or placebo. The results confirm the effectiveness of lactate infusions in evoking anxiety, extend previous hormone profiles of this maneuver, and indicate that chronic alprazolam treatment minimizes the neuroendocrine response to lactate challenges in patients with panic disorder or agoraphobia with panic attacks.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2869703     DOI: 10.1176/ajp.143.4.483

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.

Authors:  R S Kahn; G M Asnis; S Wetzler; H M van Praag
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

3.  Effects of chronic alprazolam treatment on plasma concentrations of glucocorticoids, thyroid hormones, and testosterone in cardiomyopathic hamsters.

Authors:  J E Ottenweller; W N Tapp; B H Natelson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.

Authors:  J A Den Boer; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

Review 6.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  [Physical exercise, endogenous opiates and pain regulation.].

Authors:  C Droste
Journal:  Schmerz       Date:  1991-09       Impact factor: 1.107

8.  Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior.

Authors:  Tj Sajdyk; Pl Johnson; Sd Fitz; A Shekhar
Journal:  J Psychopharmacol       Date:  2008-02-28       Impact factor: 4.153

Review 9.  Experimental panic provocation in healthy man-a translational role in anti-panic drug development?

Authors:  Michael Kellner
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 10.  Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update.

Authors:  L L Vollmer; J R Strawn; R Sah
Journal:  Transl Psychiatry       Date:  2015-05-26       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.